APA (7th ed.) Citation

DL, L., LM, K., AG, S., WJG, M., & RLM, B. (2021). Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. American journal of obstetrics and gynecology, 224(2), 200.e1-200.e9. https://doi.org/10.1016/j.ajog.2020.08.026

Chicago Style (17th ed.) Citation

DL, Loopik, Koenjer LM, Siebers AG, Melchers WJG, and Bekkers RLM. "Benefit and Burden in the Dutch Cytology-based Vs High-risk Human Papillomavirus-based Cervical Cancer screening Program." American Journal of Obstetrics and Gynecology 224, no. 2 (2021): 200.e1-200.e9. https://doi.org/10.1016/j.ajog.2020.08.026.

MLA (9th ed.) Citation

DL, Loopik, et al. "Benefit and Burden in the Dutch Cytology-based Vs High-risk Human Papillomavirus-based Cervical Cancer screening Program." American Journal of Obstetrics and Gynecology, vol. 224, no. 2, 2021, pp. 200.e1-200.e9, https://doi.org/10.1016/j.ajog.2020.08.026.